144864-75-5

Upstream product

• 6346-05-0 3-benzyloxy-4-methoxybenzaldehyde 
• 144864-77-7 (4R,5S)-3-<2-(3-benzyloxy-4-methoxyphenyl)-1-oxoethyl>-4-methyl-5-phenyl-2-oxazolidinone 
• 144864-76-6 1-methylsulfinyl-1-methylthio-2-(3-benzyloxy-4-methoxyphenyl)ethylene 
• 20445-31-2 R-(+)-α-trifluoromethyl-α-methoxy-phenylacetic acid 
• 144864-78-8 <3(2R),4R,5S>-3-<2-azido-2-(3-benzyloxy-4-methoxyphenyl)-1-oxoethyl>-4-methyl-5-phenyl-2-oxazolidinone 
• 144864-81-3 3-(2-methyl-3-methoxyphenyloxy) methyl ester 
• 144864-79-9 methyl (2R)-azido-2-(3-benzyloxy-4-methoxyphenyl)acetate 
• 159579-64-3 (2R)-2-Azido-2-<(3-(benzyloxy)-4-methoxy)phenyl>acetic acid 
• 144864-73-3 methyl (2R)-<<(1,1-dimethylethoxy)carbonyl>amino>-2-(3-hydroxy-4-methoxyphenyl)acetate 
• 17257-71-5 (S)-Mosher acid 
• 3260-88-6 1-chloro-3-methoxy-2-methylbenzene 
• 5487-33-2 O-benzylhomoisovanillic acid 

Relevant academic research and scientific papers

Studies on ristocetin A. A synthesis of protected ristomycinic acid using organomanganese chemistry

Aryl ether formation by reaction of phenoxide nucleophiles with chloroarene-Mn(CO)3 cationic complexes, followed by reaction of the aryloxyarene-Mn(CO)3 complex with chiral glycine enolate equivalents, provides methodology for the synthesis of protected ristomycinic acid derivatives in a state of high optical purity.